NASDAQ:SGRY 9 November 2025

{“@context”:”https://schema.org”,”@type “:”LiveBlogPosting”,”@id”:”https://ts2.tech/en/stock-market-today-09-11-2025/#live”,”headline”:”Stock Market Today 09.11.2025″,”description”:”Live rolling coverage of technology news: AI, chips, gadgets, software, startups, cybersecurity, telecom, and policy.”,”datePublished”:”2025-11-09T00:00:00-05:00″,”dateModified”:”2025-11-10T00:00:11-05:00″,”coverageStartTime”:”2025-11-09T00:00:00-05:00″,”coverageEndTime”:”2025-11-10T00:00:11-05:00″,”author”:{“@type”:”Organization”,”name”:”TechStock²”},”publisher”:{“@type”:”Organization”,”name”:”TechStock²”,”logo”:{“@type”:”ImageObject”,”url”:”https://ts2.tech/wp-content/uploads/2024/02/cropped-ts2-logo-google.png”}},”inLanguage”:”en-US”,”liveBlogUpdate”:[{“@type”:”BlogPosting”,”@id”:”https://ts2.tech/en/stock-market-today-09-11-2025/#live/u/355c7f22a0519fb5″,”headline”:”Surgery Partners (SGRY) Valuation Signals Undervaluation After Recent Rally”,”articleBody”:”Surgery Partners (SGRY) has gained ~9% over the last month, set against a tougher year with a -29% 1-year total shareholder return. The latest analysis argues the stock may be undervalued, with a fair value near $31 compared with the last close. The bull case rests on a narrative of high-single-digit growth and a rare, future profit multiple, supported by a shift of high-acuity procedures to outpatient settings and investments in robotics and facility